These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6010154)

  • 1. [Studies on the combined use of attenuated and live vaccines for measles. 2. Evaluation of vaccination with live vaccine after a long period following administration of the attenuated vaccine 2 or 3 times].
    Seki T
    Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1350-62. PubMed ID: 6010154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the combined use of attenuated and live vaccines for measles. 1. Evaluation of vaccination with live vaccine after administration of the attenuated vaccine once or twice].
    Seki T
    Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1340-9. PubMed ID: 6010153
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
    Wiedermann G; Ambrosch F
    Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 5. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
    Smorodintsev AA; Nasibov MN; Jakovleva NV
    Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the live AIK measles virus vaccine.
    Makino S; Sasaki K; Nakamura N; Nakagawa M; Nakajima S
    Kitasato Arch Exp Med; 1973 Dec; 46(3-4):83-92. PubMed ID: 4805362
    [No Abstract]   [Full Text] [Related]  

  • 12. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
    Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the inoculation test of measles vaccine. 2. The results of the use of inactivated measles vaccine alone and combined inactivated and attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):344-55. PubMed ID: 6070597
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live, attenuated mumps-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Feb; 278(5):227-32. PubMed ID: 4169706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of live mumps vaccine alone and in combination with measles vaccine in infants].
    Vesikari T; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Duodecim; 1982; 98(11):839-47. PubMed ID: 7106018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical serological study of combined inocculation of measles inactivated and raw vaccines. 2. KL in Kenkyukai and Arakawa inactivated vaccine and Matsumoto and Arakawa raw vaccine].
    Tanabe Y; Arai M
    Nihon Shonika Gakkai Zasshi; 1967 Apr; 71(4):425-8. PubMed ID: 6070358
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 20. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.